We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGI
801
DELISTED
MoneyGram International, Inc. New
MGI
-20,222
Closed -$174K
MIC
802
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
-6,881
Closed -$254K
MXIM
803
DELISTED
Maxim Integrated Products
MXIM
-91,065
Closed -$5.48M
SDRL
804
DELISTED
Seadrill Limited Common Stock
SDRL
-49
Closed -$3K
AKRX
805
DELISTED
Akorn Inc
AKRX
-38,343
Closed -$717K
DERM
806
DELISTED
Dermira, Inc.
DERM
-200,000
Closed -$1.6M
ARMO
807
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
-74,000
Closed -$2.77M
TWX
808
DELISTED
Time Warner Inc
TWX
-82,284
Closed -$7.78M
MON
809
DELISTED
Monsanto Co
MON
-98,561
Closed -$11.5M
GXP
810
DELISTED
Great Plains Energy Incorporated
GXP
-16,054
Closed -$510K
AVXS
811
DELISTED
AveXis, Inc. Common Stock
AVXS
-39,000
Closed -$4.82M
FMSA
812
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
-10,779
Closed -$46K
DISH
813
DELISTED
DISH Network Corp.
DISH
-15,342
Closed -$581K
WR
814
DELISTED
Westar Energy Inc
WR
-34,126
Closed -$1.79M

Similar funds

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.